In addition, we identified two novel prognostic m6A regulators (LRPPRC and FTO) in IPF for the first time and obtained a total of 100 compounds or natural products as potential drugs targeting LRPPRC and FTO in the treatment of IPF with the aid of virtual screening technology. This evidence concerns the gene FTO and idiopathic pulmonary fibrosis.